The prevalence of PAI-1 4G/5G polymorphism in women with fetal loss: First data for a Serbian population

Background: Plasminogen activator inhibitor 1 (PAI-1) is an inhibitor of fibrinolysis. The PAI-1 4G/5G polymorphism is associated with elevated plasma levels of PAI-1. Overexpression of PAI-1 and impaired fibrinolysis in homozygous carriers of the 4G/4G PAI polymorphism may lead to abnormal placenta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Đorđević Valentina, Gvozdenov Maja, Pruner Iva, Kovač Mirjana, Tomić Branko, Stanković Marija, Radojković Dragica
Formato: Artigo
Lenguaje:Inglês
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2014-01-01
Colección:Journal of Medical Biochemistry
Materias:
pai-1 4g/5g polymorphism
plasminogen activator inhibitor-1
fetal loss
Acceso en línea:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2014/1452-82581402203Q.pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares